Executive Director, Oncology Head, Translational Development
Bristol Myers Squibb
Summary
Translational Development is part of the Global Research organization in BMS and leads early and late stage translational research and development activities for the early and late-stage portfolio, supporting all therapeutic areas (heme/onc, immunology, cardiovascular, and neuroscience).
Job description
Reporting to the VP, Translational Development, the incumbent will be part of the translational team based in either Cambridge, MA or NJ and will help develop translational disease and asset strategies in solid tumor disease areas for assigned programs for FIH to approval or life-cycle management of the BMS pipeline (excluding CART). Modalities include protein degraders, ADCs, TCEs and small molecules. Key responsibility is to lead the breast and prostate disease area strategy and a cross functional team of asset and disease scientists.
Responsibilities
- Leads the development of disease and asset specific translational annual goals and objectives for Translational Development
- Builds disease area specific long term translational strategy and implementation across portfolio
- Assists in developing and maintaining group budget and workforce plan
- Represents Translational Development in cross-functional Strategy Teams and business development teams
- Interfaces with commercial including early commercialization group and Medical Affairs to provide scientific support for cross-functional TD goals
- Accountable for regulatory submissions, regulatory interactions, health authority interactions for the team
- Communicates regularly and prepares and makes presentations for leadership and externally as required
- Collaborates with TD Lab Head in setting translational lab research objectives
- Collaborates with informatics, data science and biostats heads in setting translational research objectives
- Collaborates with Diagnostic Head to coordinate diagnostic needs and patient selection hypotheses
- Collaborates with early clinical development and discovery teams to leverage TD data and insights for early programs
- Evaluating, in conjunction with BD and established teams, the potential for in-licensing opportunities
- Liaises with key BMS research discovery and early translational groups to help formulate and execute on new hypotheses driving new clinical biomarker assays
- Serves as translational representative on BMS cross functional Disease Strategy Team
- Leads small and large strategic collaborations with academia and industry partners to identify biobanks, clinical trials and existing databases
- Serves as a conduit to external thought leaders and scientific consultants
Qualifications
- MD/PhD in Oncology or related field with minimum 15 years industry setting
- Track record in large and/or small companies, leading innovative efforts to deploy translational strategies
- Excellent communication, managerial and scientific qualities
- Ability to interact effectively across boundaries using influencing and relationship building skills
- Competence in analysis and solving of problems, and the ability to prioritize and make tradeoffs to achieve goals
Technical Skills
- In-depth understanding of Oncology specifically Breast Cancer and/or prostate, clinical landscape, evolving therapy, competitive landscape
- Strong understanding of clinical, translational and mechanistic data with therapeutics development
- Strong background in genetics, cancer biology and/or immunology
- Experience in deploying biomarkers for trial design including MRD guided designs, endpoints
- Experience in reverse translation with discovery experience a plus
- Experience in disease strategy development working cross-functionally
- Understanding of late-stage drug and translational development process
- Proven track record of running first in human trials through proof of concept, IND and NDA submissions, approvals, regulatory interactions and label negotiations
- Proven ability to work with global disease teams to develop strategies to support life cycle management efforts tailored to regional markets (i.e., US, EU, CAN)
- Strong verbal and written communication skills with experience in developing written documents such as primary manuscripts/publications/reviews, disease strategies, mechanism slides, regulatory submissions, strategic communications, literature/market/pt segment analyses
- Proven success in spearheading collaborative scientific initiatives internally and with academic partners
Requirements
- MD/PhD in Oncology or related field
- Minimum 15 years industry experience
- Track record leading translational strategies in large and/or small companies
- Excellent communication, managerial and scientific qualities
- Ability to interact effectively across boundaries using influencing and relationship building skills
- Competence in analysis and problem solving, ability to prioritize and make tradeoffs
- In-depth understanding of Oncology, specifically Breast Cancer and/or prostate
- Strong understanding of clinical, translational and mechanistic data with therapeutics development
- Strong background in genetics, cancer biology and/or immunology
- Experience deploying biomarkers for trial design including MRD guided designs and endpoints
- Experience in disease strategy development working cross-functionally
- Understanding of late-stage drug and translational development process
- Proven track record running first in human trials through proof of concept, IND and NDA submissions, approvals, regulatory interactions and label negotiations
- Proven ability to work with global disease teams to support life cycle management across regional markets
- Strong verbal and written communication skills
- Proven success spearheading collaborative scientific initiatives internally and with academic partners
- Management experience with ability to set priorities, direct projects and implement complex strategies
- Highly effective teamwork and interpersonal skills
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Time Off
- 11 Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Parental & Caregiver Leave
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.